Harvard Bioscience: Q2 Earnings Snapshot

Harvard Bioscience Inc. reported a $2.9 million loss in its second quarter, while posting revenue of $22.7 million for the period. Losses, adjusted for non-recurring costs and amortization costs, totaled 14 cents per share. For the current quarter ending in September, the company expects revenue between $21 million to $22.6 million.